NPMc+ AML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Oral Arsenic Trioxide for NPM1-mutated AML (NCT04689815) | The University of Hong Kong | 2021-01-01 |
Track NPMc+ AML automatically
Every clearance here is in the API, with alerts when new ones post.